The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer.
Bobby Chi-Hung Liaw
No relevant relationships to disclose
Sonia Maria Seng
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose
Che-Kai Tsao
No relevant relationships to disclose
Phillip G. Febbo
No relevant relationships to disclose
William K. Oh
No relevant relationships to disclose